Juvenescence: Investing in the age of longevityThis new book by Jim Mellon and Al Chalabi is a layman's guide to longevity. It investigates the new technologies and explains how to benefit from the life extending technologies both personally and professionally. It helps readers unravel the science, offers ideas on potential investment and reveals the views of the key opinion leaders. |
Common terms and phrases
activity Additionally adult age-related Alzheimer’s animals anti-ageing apoptosis Aubrey de Grey autophagy biological biomarkers Biosciences blood body body’s brain cancer carbs cardiovascular disease cause cellular clinical company’s CRISPR currently damage death decades dementia developed diet diseases of ageing drugs effects expectancy factors function gene genetic genome glucose Hayflick Hayflick Limit heart disease hormone human immune system important improve increase inhibitors Institute insulin Key Opinion Leaders lead levels lifespan longevity lung medicine metabolic metformin mice million mitochondrial models molecule mTOR mTORC1 mutations NAD+ NASDAQ Novartis obesity older organs Parkinson’s pathways patients population production programme proteins rapalogs rapamycin recently repair replacement result resveratrol risk scientists senescent senescent cells senolytic sirtuins specific stem cells sugar T-cells Targets in Ageing telomerase telomeres Therapeutics therapies tissue transplantation trials tumour type 2 diabetes vitamin worms